Roche CEO outlines acquisition plans

Roche Holding CEO Franz Humer has ruled out any big takeover moves, but signaled the European drug giant was very interested in acquiring new products, technologies and smaller developers. Noting that none of Roche's biggest drug producers are facing the loss of patent protection in the near future, Humer said he was bullish about the company's prospects. "We are at the start of a wave of new product launches...(with) significant development possibilities, thanks to new applications and new indications," said Humer in an interview with Finanz und Wirtschaft.

- read this AFX report on Humer